-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
-
Summary
-
Apellis Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2018 to Q2 2024.
- Apellis Pharmaceuticals, Inc. Return On Assets for the quarter ending June 30, 2024 was -39.8 %, a 46.5% increase year-over-year.
- Apellis Pharmaceuticals, Inc. annual Return On Assets for 2023 was -60.4 %, a 12.5% increase from 2022.
- Apellis Pharmaceuticals, Inc. annual Return On Assets for 2022 was -69 %, a 32.6% increase from 2021.
- Apellis Pharmaceuticals, Inc. annual Return On Assets for 2021 was -102 %, a 144% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)